ASR Vermogensbeheer’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.29M Sell
19,405
-14,902
-43% -$4.12M 0.04% 291
2026
Q1
$10.1M Buy
34,307
+595
+2% +$177K 0.12% 165
2025
Q4
$9.21M Buy
33,712
+5,233
+18% +$1.42M 0.11% 174
2025
Q3
$7.69M Sell
28,479
-81
-0.3% -$22K 0.09% 187
2025
Q2
$7.87M Buy
28,560
+8,623
+43% +$2.34M 0.1% 191
2025
Q1
$5.29M Buy
+19,937
New +$4.92M 0.08% 222

Other funds holding CME

ASR Vermogensbeheer's CME Position: Q2 2026 in Review

ASR Vermogensbeheer reduced its CME Group (CME) stake by 43% in Q2 2026, selling an estimated $4.12M and leaving 19,405 shares worth $4.29M. The position accounts for 0.04% of the portfolio, ranked #291.

ASR Vermogensbeheer first reported a position in CME in Q1 2025 and has held it in 6 quarters since. The position peaked at $10.1M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • ASR Vermogensbeheer held 19,405 shares of CME Group worth $4.29M as of Q2 2026.
  • ASR Vermogensbeheer sold 14,902 CME Group shares in Q2 2026, an estimated $4.12M.
  • CME Group made up 0.04% of ASR Vermogensbeheer's portfolio in Q2 2026, its #291 holding.
  • ASR Vermogensbeheer first reported a position in CME Group in Q1 2025 and has held it in 6 quarters since.
  • ASR Vermogensbeheer's CME Group position peaked at $10.1M in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.